Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

NIH 4OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 1152Prostatic Neoplasms 642Neoplasms 581Carcinoma, Non-Small-Cell Lung 488Multiple Myeloma 483Leukemia, Myeloid, Acute 461Leukemia 418Lung Neoplasms 399Lymphoma 381Leukemia, Lymphocytic, Chronic, B-Cell 332Precursor Cell Lymphoblastic Leukemia-Lymphoma 327Lymphoma, Non-Hodgkin 326Colorectal Neoplasms 310Pancreatic Neoplasms 306Neoplasm Metastasis 302Myelodysplastic Syndromes 301Melanoma 286Hodgkin Disease 253Head and Neck Neoplasms 249Brain Neoplasms 231Lymphoma, Follicular 224Ovarian Neoplasms 221Recurrence 220Glioblastoma 215Lymphoma, Mantle-Cell 211Lymphoma, Large B-Cell, Diffuse 209Squamous Cell Carcinoma of Head and Neck 176Colonic Neoplasms 162Carcinoma, Renal Cell 158Carcinoma, Hepatocellular 154

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Has results × Rhabdomyosarcoma, Alveolar × Clear all
NCT00924950 2019-04-18

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

University of California, San Francisco

Phase 4 Terminated
35 enrolled 3 charts
Sarcoma

Psoriasis, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡